儿童实体器官移植后癌症风险研究
结果显示儿童移植受者多种癌症风险显著升高,其中非霍奇金淋巴瘤占诊断癌症的71%,且移植后第一年风险最高。
要点
- 儿童移植受者非霍奇金淋巴瘤风险显著升高,SIR为212。
- 移植时EBV血清学阴性者非霍奇金淋巴瘤风险更高,SIR为446。
- 移植后第一年及肠道移植受者非霍奇金淋巴瘤风险尤为突出。
核心结论
- 儿童实体器官移植受者多种癌症风险显著增加,非霍奇金淋巴瘤占诊断癌症的大多数。
研究设计与样本
- 采用标准化发病比(SIR)比较受者与一般人群的癌症发生率,并用Cox回归分析非霍奇金淋巴瘤风险因素。
主要发现
- 共诊断392例癌症,其中279例(71%)为非霍奇金淋巴瘤。
- 非霍奇金淋巴瘤SIR为212(95%CI=188-238),霍奇金淋巴瘤SIR为19(95%CI=13-26),白血病SIR为4(95%CI=2-7),骨髓瘤SIR为229(95%CI=47-671)。
- 肝脏、软组织、卵巢、外阴、睾丸、膀胱、肾脏和甲状腺癌的发病率也显著增加。
- 移植时小于5岁受者第一年内非霍奇金淋巴瘤SIR为313,移植时EBV血清学阴性者SIR为446,肠道移植受者SIR为1280。
- 多变量分析中,EBV血清学阴性、移植后第一年、肠道移植和诱导免疫抑制与非霍奇金淋巴瘤发生率升高独立相关。
临床怎么用
- 儿童实体器官移植后应高度警惕非霍奇金淋巴瘤风险,尤其在移植后第一年。
- 对移植时EBV血清学阴性及接受肠道移植的儿童受者,需加强监测与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effects of pediatric solid organ transplantation on cancer risk may differ from those observed in adult recipients. We described cancers in pediatric recipients and compared incidence to the general population. METHODS: The US transplant registry was linked to 16 cancer registries to identify cancer diagnoses among recipients <18 years old at transplant. Standardized incidence ratios (SIRs) were estimated by dividing observed cancer counts among recipients by expected counts based on the general population rates. Cox regression was used to estimate the associations between recipient characteristics and non-Hodgkin's lymphoma (NHL) risk. RESULTS: Among 17 958 pediatric recipients, 392 cancers were diagnosed, of which 279 (71%) were NHL. Compared with the general population, incidence was significantly increased for NHL (SIR = 212, 95% confidence interval [CI] = 188-238), Hodgkin's lymphoma (SIR = 19, 95% CI = 13-26), leukemia (SIR = 4, 95% CI = 2-7), myeloma (SIR = 229, 95% CI = 47-671), and cancers of the liver, soft tissue, ovary, vulva, testis, bladder, kidney, and thyroid. NHL risk was highest during the first year after transplantation among recipients <5 years old at transplant (SIR = 313), among recipients seronegative for Epstein-Barr virus (EBV) at transplant (SIR = 446), and among intestine transplant recipients (SIR = 1280). In multivariable analyses, seronegative EBV status, the first year after transplantation, intestine transplantation, and induction immunosuppression were independently associated with higher NHL incidence. CONCLUSIONS: Pediatric recipients have a markedly increased risk for many cancers. NHL constitutes the majority of diagnosed cancers, with the highest risk occurring in the first year after transplantation. NHL risk was high in recipients susceptible to primary EBV infection after transplant and in intestine transplant recipients, perhaps due to EBV transmission in the donor organ.
引用
- Yanik EL, Smith JM, Shiels MS, et al. Cancer Risk After Pediatric Solid Organ Transplantation. Pediatrics. 2017. PMID: 28557749. doi:10.1542/peds.2016-3893
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。